Report #2863352

Received Oct 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Not recovered
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	1	UNK	LA

Symptoms (1)

Paraesthesia

Symptom narrative

Tingling skin; This non-serious case was reported by a physician via sales rep and described the occurrence of tingling skin in a 58-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Shingrix (left arm). On an unknown date, an unknown time after receiving Shingrix, the patient experienced tingling skin (Verbatim: Tingling skin). The outcome of the tingling skin was not resolved. The reporter considered the tingling skin to be related to Shingrix. The company considered the tingling skin to be related to Shingrix. Additional Information: GSK Receipt Date: 18-SEP-2025 Tingling skin was reported as worsened. The patient was coming into the office afternoon, and additional information will be available upon examination.